Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) registered 87.08% higher net profit after tax at EGP 405.374 million in fiscal year (FY) 2024/2025
Updated 8/10/2025 2:03:00 AMAlexandria Company for Pharmaceuticals and Chemical Industries reported a 70.6% year-on-year (YoY) increase in its net profit after tax in the first 11 months of fiscal year (FY) 2023/2024.
Updated 7/14/2024 11:05:00 AMAlexandria Company for Pharmaceuticals and Chemical Industries has decided to distribute cash dividends of EGP 13 per share to shareholders for the fiscal year (FY) 2022/2023.
Updated 11/12/2023 9:11:00 AMAlexandria Company for Pharmaceuticals and Chemical Industries posted a 71.1% year-on-year (YoY) increase in its net profit after tax in the first quarter (Q1) of fiscal year (FY) 2023/2024.
Updated 11/5/2023 11:19:00 AMAlexandria Company for Pharmaceuticals and Chemical Industries posted a 7.7% year-on-year (YoY) increase in its net profit after tax in the fiscal year (FY) 2022/2023.
Updated 9/6/2023 9:18:00 AMAlex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
Updated 5/14/2023 9:52:00 AM